|Alterola Biotech Inc -- USA Stock|| |
USD 1.55 0.00 0.00%
President CEO, Treasurer, Secretary, Director
Mr. Michael Frederick Freitag was appointed as President, Chief Executive Officer, Treasurer, Secretary, Director of the Company
CEO Since 2017
Freitag has over 10 years of experience with pharmaceutical scientific development and sales growth in the medical technology industry. From February 2016 to the present Mr. Freitag was a Process Specialist on at MSAT, Ballerup, Denmark. From August 2015 to February 2016, he was Process Technology Consultant at NNE Pharmaplan, Gentofte, Denmark. From Sept 2013 to August 2015, he was Process Specialist/Global Technology Optimization at Xellia ApS, Copenhagen, Denmark. From April 2013 to Sept 2013, he was Large Scale Mfg Associate III, at Biogen Aps, Hiller?d, Denmark.
The company has return on total asset (ROA)
of (133.34) %
which means that it has lost $133.34 on every $100 spent on asset. This is way below average.
The company currently holds 175.75 K in liabilities with Debt to Equity (D/E) ratio of 0.67 which is about average as compared to similar companies. Alterola Biotech Inc has Current Ratio of 0.01 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Alterola Biotech, Inc. was founded in 2008 and is based in Walnut, California. Alterola Biotech is traded on OTC Market in USA.Alterola Biotech Inc (ALTA) is traded on OTC Market in USA. It is located in 340 South Lemon Avenue and employs 1 people.